In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Volpara Health Technologies Ltd.

volparasolutions.com

Latest From Volpara Health Technologies Ltd.

Market Intel: Breast Imaging Market Driven By AI, Technological Innovation

The global market for breast cancer imaging and biopsy technologies is expected to reach $5.8bn by 2022, a CAGR of 5.9%, driven by innovation technologies and machine-learning tools that serve as "second readers" to help radiologists triage images and find cancers. Many radiologists believe that mammography will remain the most widely used screening tool, but that digital breast tomosynthesis will ultimately become the gold standard. Here's a close look at the overall breast imaging and biopsy market, highlighting different modalities and key players, and offering the real-world use perspective from three radiologists at Kaiser Permanente, San Diego.

Commercial Market Intelligence

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Deals Market Intelligence

Q2 Breathes A Little Life Into Medtech IPO Scene

After a lackluster first quarter, the medtech IPO scene is gradually livening up with several companies their shares successfully floated on the public markets for the first time in the second quarter. But activity levels are still a far cry from the bonanza of 2015.

Commercial Companies

Medical Device Deals Update, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2016.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
      • X-ray
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Volpara Solutions Ltd.
  • Matakina Technology Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • New Zealand
  • Parent & Subsidiaries
  • Volpara Health Technologies Ltd.
  • Senior Management
  • Ralph Highnam, PhD, CEO
    Brian Leighs, CFO
    Julian Marshall, Chief Marketing Officer
    David Murray, PhD, CTO
  • Contact Info
  • Volpara Health Technologies Ltd.
    Phone: 4 499 6029
    Level 12, 86 Victoria St.
    Wellington, 6011
    New Zealand
Advertisement
Advertisement
UsernamePublicRestriction

Register